Epidemiology and economic impact of obesity and type 2 diabetes

Surgical Clinics of North America

Volumn 91, Issue 6, 2011, Pages 1163-1172

  Shamseddeen, Hazem ^a   Getty, Jorge Zelada ^a   Hamdallah, Isam N ^a   Ali, Mohamed R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bariatric surgery; Diabetes; Epidemic; Morbid obesity; Obesity

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6; LEPTIN; METFORMIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TETRAHYDROLIPSTATIN; TUMOR NECROSIS FACTOR ALPHA;

BARIATRIC SURGERY; BODY MASS; BODY WEIGHT; DIET THERAPY; DISEASE ASSOCIATION; ECONOMIC ASPECT; EXERCISE; GENETIC PREDISPOSITION; HEALTH CARE COST; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; UNITED STATES; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION;

ADIPOSITY; BODY COMPOSITION; BODY MASS INDEX; COMORBIDITY; COST OF ILLNESS; DIABETES MELLITUS, TYPE 2; HEALTH CARE COSTS; HUMANS; LIFE STYLE; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; UNITED STATES; WORLD HEALTH;

EID: 80455176654     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2011.08.001     Document Type: Review

References (54)

1. Kelly T., Yang W., Chen C.S., et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008, 32:1431-1437.
2. Wang Y., Beydoun M.A., Liang L., et al. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 2008, 16:2323-2330.
3. Daniels J. Obesity: America's epidemic. Am J Nurs 2006, 106:40-49. [quiz: 9-50].
4. Anonymous Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894:i-xii. 1-253.
5. WHO/IASO/IOTF The Asia-Pacific perspective: redefining obesity and its treatment 2000, Health Communications Australia, Melbourne (Australia).
6. Anonymous Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163.
7. NIH-NHLBI North American Association for the Study of Obesity. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults 2000, National Institutes of Health, Bethesda (MD).
8. Geer E.B., Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med 2009, 6(Suppl 1):60-75.
9. Huxley R., Mendis S., Zheleznyakov E., et al. Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk-a review of the literature. Eur J Clin Nutr 2010, 64:16-22.
10. Oliveira A., Rodriguez-Artalejo F., Severo M., et al. Indices of central and peripheral body fat: association with non-fatal acute myocardial infarction. Int J Obes (Lond) 2010, 34:733-741.
11. Seidell J.C. Waist circumference and waist/hip ratio in relation to all-cause mortality, cancer and sleep apnea. Eur J Clin Nutr 2010, 64:35-41.
12. Yusuf S., Hawken S., Ounpuu S., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005, 366:1640-1649.
13. Anonymous Central obesity and risk of cardiovascular disease in the Asia Pacific Region. Asia Pac J Clin Nutr 2006, 15:287-292.
14. Bray G.A. Medical consequences of obesity. J Clin Endocrinol Metab 2004, 89:2583-2589.
15. Field A.E., Coakley E.H., Must A., et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001, 161:1581-1586.
16. Adams K.F., Schatzkin A., Harris T.B., et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006, 355:763-778.
17. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
18. Low S., Chin M.C., Deurenberg-Yap M. Review on epidemic of obesity. Ann Acad Med Singapore 2009, 38:57-59.
19. International Obesity Task Force The global challenge of obesity and the International Obesity Task Force 2002, International Union of Nutritional Sciences, Available at:, Accessed March 15, 2011. http://www.iuns.org/features/obesity/obesity.htm.
20. Lawlor D.A., Chaturvedi N. Treatment and prevention of obesity-are there critical periods for intervention?. Int J Epidemiol 2006, 35:3-9.
21. Dixon J.B. The effect of obesity on health outcomes. Mol Cell Endocrinol 2010, 316:104-108.
22. Flegal K.M., Graubard B.I., Williamson D.F., et al. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007, 298:2028-2037.
23. Peeters A., Barendregt J.J., Willekens F., et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003, 138:24-32.
24. Calle E.E., Rodriguez C., Walker-Thurmond K., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625-1638.
25. Finkelstein E.A., Trogdon J.G., Cohen J.W., et al. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 2009, 28:w822-w831.
26. Cawley J., Rizzo J.A., Haas K. Occupation-specific absenteeism costs associated with obesity and morbid obesity. J Occup Environ Med 2007, 49:1317-1324.
27. Withrow D., Alter D.A. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev 2011, 12:131-141.
28. CDC National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 2011, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta (GA).
29. IDF IDF diabetes atlas 2009, International Diabetes Federation, Brussels (Belgium). 4th edition.
30. World Health Organization Diabetes fact sheet no 213 2011, WHO Media Center, Available at:, Accessed March 15, 2011. http://www.who.int/mediacentre/factsheets/fs312/en.
31. Roglic G., Unwin N., Bennett P.H., et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005, 28:2130-2135.
32. Narayan K.M., Boyle J.P., Thompson T.J., et al. Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290:1884-1890.
33. Zhang P., Zhang X., Brown J., et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:293-301.
34. Dall T.M., Zhang Y., Chen Y.J., et al. The economic burden of diabetes. Health Aff (Millwood) 2010, 29:297-303.
35. Farag Y.M., Gaballa M.R. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant 2011, 26:28-35.
36. Gaziano T.A., Bitton A., Anand S., et al. The global cost of nonoptimal blood pressure. J Hypertens 2009, 27:1472-1477.
37. Dixon J.B. Obesity and diabetes: the impact of bariatric surgery on type-2 diabetes. World J Surg 2009, 33(10):2014-2021.
38. Li S., Zhao J.H., Luan J., et al. Genetic predisposition to obesity leads to increased risk of type 2 diabetes. Diabetologia 2011, 54:776-782.
39. Ouchi N., Parker J.L., Lugus J.J., et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.
40. Leibson C.L., Williamson D.F., Melton L.J., et al. Temporal trends in BMI among adults with diabetes. Diabetes Care 2001, 24:1584-1589.
41. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289:76-79.
42. Schauer P.R., Burguera B., Ikramuddin S., et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003, 238:467-484. [discussion: 84-5].
43. Williamson D.F., Pamuk E., Thun M., et al. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol 1995, 141:1128-1141.
44. Colditz G.A., Willett W.C., Rotnitzky A., et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995, 122:481-486.
45. Colagiuri S. Diabesity: therapeutic options. Diabetes Obes Metab 2010, 12:463-473.
46. Siram A.T., Yanagisawa R., Skamagas M. Weight management in type 2 diabetes mellitus. Mt Sinai J Med 2010, 77:533-548.
47. Ioannides-Demos L.L., Piccenna L., McNeil J.J. Pharmacotherapies for obesity: past, current, and future therapies. J Obes 2011, 2011:179674.
48. Padwal R.S., Majumdar S.R. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007, 369:71-77.
49. Monkhouse S.J., Morgan J.D., Bates S.E., et al. An overview of the management of morbid obesity. Postgrad Med J 2009, 85:678-681.
50. Goodrick G.K., Poston W.S., Foreyt J.P. Methods for voluntary weight loss and control: update 1996. Nutrition 1996, 12:672-676.
51. Sjostrom L., Lindroos A.K., Peltonen M., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004, 351:2683-2693.
52. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292:1724-1737.
53. Sjostrom L., Narbro K., Sjostrom C.D., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007, 357:741-752.
54. Adams T.D., Gress R.E., Smith S.C., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007, 357:753-761.